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Chemokines Trigger Immediate b2 Integrin Affinity
and Mobility Changes: Differential Regulation
and Roles in Lymphocyte Arrest under Flow
chemokine family can trigger very rapid integrin-depen-
dent adhesion of leukocytes, and they have been pro-
posed to be physiological activators of integrin-depen-
dent adhesion of circulating lymphocytes to venular
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ras and rho-related small GTPases, MAP kinases, pro-Italy
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ning to be elucidated. Recently, the small GTPase RhoAThe Center for Molecular Biology and Medicine
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chemokines in polymorphonuclear cells and lympho-
cytes (Laudanna et al., 1996, 1998). Considerable inter-
est has also focused on the PI(3)K family of lipid kinases.Summary
A correlation between PI(3)K activity and chemokine-
induced lymphocyte chemotaxis has been reportedChemokines trigger rapid integrin-dependent lympho-
(Turner et al., 1995), and PI(3)Kg, the isoform activatedcyte arrest to vascular endothelium. We show that
by G protein-coupled receptors, has been functionallythe chemokines SLC, ELC, and SDF-1a rapidly induce
implicated in neutrophil migration (Hirsch et al., 2000).lateral mobility and transient increase of affinity of the
However, involvement of PI(3)K in rapid integrin-depen-b2 integrin LFA-1. Inhibition of phosphatidylinositol
dent arrest triggered in lymphocytes by chemokines has3-OH kinase (PI(3)K) activity blocks mobility but not
not been examined.affinity changes and prevents lymphocyte adhesion
Here, we analyzed the modality of b2 integrin trig-to ICAM-1 immobilized at low but not high densities,
gering leading to rapid lymphocyte arrest and investi-suggesting that mobility enhances the frequency of
gated the involvement of PI(3)K. We show that chemo-encounters between high-affinity integrin and ligand
kines rapidly trigger a high-affinity state of the b2 integrinbut that at higher ligand density affinity changes are
LFA-1. In addition, chemokines stimulate LFA-1 lateralsufficient for arrest. Thus, chemokines trigger, through
mobility on the plasma membrane leading to very rapiddistinct signaling pathways, both a high-affinity state
localization to clusters and large polar patches. Rapidand lateral mobility of LFA-1 that can coordinately de-
LFA-1 lateral mobility, but not induction of the high-termine the vascular arrest of circulating lymphocytes
affinity state, is controlled by a PI(3)K-dependent signal-under physiologic conditions.
ing pathway. Moreover, while triggering of integrin affin-
ity may contribute to adhesion under all conditions and
Introduction is likely to be sufficient for lymphocyte arrest on ligand-
rich high endothelial venules (HEV), induced mobility
Leukocyte recruitment from the blood is a central event of the integrin appears to be critical for lymphocyte
in the regulation of immune responses. Activating fac- adhesion under conditions of low but not high ligand
tors are major players in leukocyte recruitment, as integ- density. Thus, integrin lateral mobility and induction of
rins, which are critical to stabilize the interaction of circu- high-affinity state can play a cooperative role in mediat-
lating leukocytes with the vessels, do not mediate firm ing rapid lymphocyte arrest under physiological condi-
adhesion unless activated. Two major modes of integrin tions. The findings suggest that proadhesive chemo-
function modulation have been demonstrated, involving kines utilize multiple signaling pathways to trigger
(1) increase of receptor affinity by conformational integrin-dependent lymphocyte arrest, during which
changes of the heterodimer or (2) lateral mobility of the rapid integrin lateral mobility facilitates encounters be-
receptor on the plasma membrane leading to formation tween immobilized ligands and integrin heterodimers
of clusters of heterodimers and increased avidity (Baz- triggered to a high-affinity state.
zoni and Hemler, 1998). Whatever the mechanism, sig-
naling events triggered by physiologic lymphocyte pro- Results
adhesive agonists must be very efficient as cell arrest
under flow occurs within seconds. Polypeptides of the An In Vitro Model of Primary Mouse Lymphocyte
LFA-1-Mediated Rapid Adhesion
Mouse lymphocytes respond to the chemokines SDF-§ To whom correspondence should be addressed (e-mail: clauda@
borgoroma.univr.it). 1a (CXCL12), ELC (CCL19), and SLC (CCL21) with robust
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Figure 1. Role of PI(3)K in In Vitro and In Vivo
Rapid Lymphocyte Adhesion
(A) Lymphocytes on slides coated with ICAM-1
at 500 sites/mm2 were stimulated at 378C
for the indicated time with buffer, no agonist,
or with 1 mM chemokine. Mean 6 SD counts
of bound cells in three experiments.
(B) Lymphocytes were preincubated in buffer
containing DMSO alone (no agonist and con-
trol) or plus the indicated concentrations of
wortmannin and LY294002, added to slides
coated with ICAM-1 at 500 sites/mm2, and
stimulated at 378C for 2 min with buffer, no
agonist, with 1 mM chemokine, or for 10 min
with 100 ng/ml PMA. Mean 6 SD counts of
bound cells in three experiments.
(C) Lymphocytes were stimulated at 378C for
30 s under stirring with buffer (no agonist) or
with 1 mM chemokine, or for 10 min with 100
ng/ml PMA. Shown are radioactive chromato-
grams of PtdIns with CPM. A representative
experiment of three similar experiments is
presented.
(D) [32P]orthophosphate-labeled lymphocytes
were pretreated as in (B) and then stimulated
at 378C for 30 s under stirring with buffer (no
agonist 5 n.a.) or with 1 mM SLC. Shown are
plots of measured radioactivity and radioac-
tive chromatograms of PtdIns. A representa-
tive experiment of two is presented.
(E) Lymphocytes were preincubated in buffer
containing DMSO (control) or plus 100 nM
wortmannin or 20 mM LY294002 and then in-
jected in the mouse tail vein. Mean 6 SD per-
centage of total interacting cells (only rolling
and rolling plus sticking cells) in four experi-
ments.
adhesion to immobilized ICAM-1 (Figure 1A), as reported 1B, wortmannin inhibited SDF-1a, ELC, and SLC-induced
lymphocyte adhesion to ICAM-1 in a dose-dependentfor human lymphocytes (Campbell et al., 1998). Integrin
manner. To further support the involvement of PI(3)Ktriggering is very rapid, as adhesion is significant even
in chemokine-triggered lymphocyte adhesion, we usedafter 10 s, the earliest time-point measurable, and is
LY294002, a specific but reversible PI(3)K inhibitormaximal after 2–3 min. Consistent with previous studies,
(Vlahos et al., 1994). As shown in Figure 1B, LY294002PTX pretreatment of lymphocytes totally prevents bind-
blocked in dose-dependent manner SDF-1a, ELC, anding induced by the three chemokines. PTX effect was
SLC-induced lymphocyte adhesion to ICAM-1. In con-not reversed by the PKA inhibitors, thus showing that
trast, PMA-induced adhesion was not sensitive to wort-the PTX inhibitory effect is not due to a concurrent cAMP
mannin or to LY294002 (Figure 1B).increase but to inhibition of Gi-type heterotrimeric G
Consistent with these data, chemokines triggered aproteins and dependent signaling pathways (data not
rapid increase of PI(3)K activity (Figure 1C). ELC wasshown). Interestingly, lymphocyte adhesion to ICAM-1
the most potent PI(3)K agonist, with 2.6-fold increasewas rapidly downregulated, with an average of 36%,
with respect to untreated lymphocytes; SDF-1a and SLC64%, and 83% of the cells detaching within 4, 5, and 6
triggered a 2- and 1.8-fold increase, respectively. In con-min, respectively.
trast, 10 min stimulation with PMA did not increase
PI(3)K activity. Importantly, wortmannin and LY294002
PI(3)K Activity Is Involved in Chemokine-Triggered blocked PIP3 accumulation in a dose-dependent man-
LFA-1-Mediated Rapid Lymphocyte Adhesion ner (Figure 1D), whereas intracellular Ca21 increase trig-
to ICAM-1 gered by chemokines and cell viability, as measured by
To study the involvement of PI(3)K in the activation of trypan blue exclusion, were unaffected (data not shown).
integrin-dependent lymphocyte adhesion by chemo- These data suggest that a PI(3)K activity can be critical
kines, we first used the irreversible PI(3)K inhibitor wort- to chemokine induction of LFA-1-dependent lympho-
cyte adhesion.mannin (Arcaro and Wymann, 1993). As shown in Figure
Chemokine-Triggered Integrin Affinity and Mobility
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Figure 2. Involvement of PI(3)K in Chemokine-
Triggered Lymphocyte Adhesion Inversely
Correlates with the Site Density of Immobi-
lized ICAM-1
(A) Eighteen-well glass slides were coated
with ICAM-1 at the indicated number of sites/
mm2. Lymphocytes were preincubated in
buffer containing DMSO (no agonist and con-
trol) or plus 100 nM wortmannin and then
stimulated at 378C for 2 min with buffer, no
agonist, or with 1 mM chemokine.
(B) As above, but pretreatment was with 20
mM LY294002. Mean 6 SD counts of bound
cells in three to five experiments.
PI(3)K Activity Is Not Involved in Lymphocyte tance of such different mechanisms might depend on
integrin ligand density. Integrin encounters with ligandAdhesion to High Endothelial Venules
in Peyer’s Patches are facilitated when a high density of ligand is presented
to the cell. When we evaluated the ICAM-1 site densityIn vitro chemokine-induced adhesion to ICAM-1 is a
model resembling the Gai-linked receptor-triggered on HEV in Peyer’s patches, the results showed an aver-
age of 13.800 6 1500 sites/mm2. This is about 27 timesrapid adhesion of circulating lymphocyte to HEV in
lymph nodes and Peyer’s patches. the number of sites/mm2 immobilized in our initial in
vitro adhesion assay, where the amount of ICAM-1 wasWe analyzed the effect of the PI(3)K inhibitors on the
behavior of lymphocytes interacting with HEV in exteri- titered down to 500 sites/mm2.
To evaluate the importance of ICAM-1 density in wort-orized Peyer’s patches using intravital microscopy. As
shown in Figure 1E, pretreatment of lymphocytes with mannin and LY294002-induced inhibition of lymphocyte
adhesion, we performed adhesion assays on surfaceswortmannin or LY294002 had no effect on the activation-
independent lymphocyte tethering and rolling. Surpris- coated with increasing densities of ICAM-1. As shown
in Figures 2A and 2B, wortmannin as well as LY294002ingly, activation-dependent lymphocyte arrest on HEV
was also unaffected by wortmannin and by LY294002. inhibited SDF-1a, ELC, and SLC-triggered adhesion to
ICAM-1 immobilized at densities between z500 to 1500Importantly, the lack of effect of inhibitors was not due
to a wash-out effect, as chemokine-triggered in vitro sites/mm2, with an average inhibition of 80 6 11% and
81 6 5% for wortmannin and LY294002, respectively.adhesion was still inhibited in pretreated cells main-
tained in culture without inhibitors for 4 hr (data not Surprisingly, at ICAM-1 densities between z3000 to
6000 sites/mm2, chemokine-induced adhesion was muchshown). Thus, wortmannin-sensitive PI(3)K activity is not
required for chemokine-triggered integrin-dependent less sensitive to wortmannin or LY294002 (15 6 10% and
16 6 11% inhibition, respectively). Thus, the requirementarrest of circulating lymphocytes in HEV.
for PI(3)K activity inversely correlates with the density
of integrin ligand presented to the cell.Involvement of PI(3)K in Chemokine-Triggered
Lymphocyte Adhesion Inversely Correlates
with the Density of Immobilized ICAM-1 Chemokines Rapidly Trigger LFA-1 Lateral Mobility
on the Plasma MembraneThe lack of effect of wortmannin and LY294002 on lym-
phocyte arrest in Peyer’s patches HEV clearly contrasts The previous data suggest that chemokines utilize dif-
ferent mechanisms to trigger lymphocytes adhesion towith their effect in our in vitro adhesion assay, sug-
gesting that the in vitro model of rapid integrin activation ICAM-1 immobilized at low or high density. We hypothe-
sized that adhesion to low-density ICAM-1 might re-we employed was not an accurate representation of
the physiological Gai-linked receptor-triggered integrin quire, to allow sufficient numbers of contacts between
integrins and ligands, the induction of integrin mobilityactivation occurring in vivo.
The discrepancy between in vivo and in vitro effects on the plasma membrane leading to rapid LFA-1 recruit-
ment and facilitated encountering with ICAM-1. We usedof wortmannin and LY294002 might reflect the existence
of PI(3)K-independent, as well as PI(3)K-dependent, confocal microscopy to evaluate LFA-1 surface redistri-
bution in lymphocytes stimulated with chemokines. Asmechanisms of LFA-1 activation. Particularly, it seemed
possible that PI(3)K was not activated or, more likely, shown in Figure 3A and in Table 1, in unstimulated lym-
phocytes LFA-1 is disperse. Stimulation with SLC forwas activated but not necessary to signaling cascades
responsible for chemokine-triggered lymphocyte arrest 2 min triggered a dramatic LFA-1 redistribution, with
formation of clusters and large polar patches. Analogouson HEV in vivo. We hypothesized that the relative impor-
Immunity
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Figure 3. SLC Triggers Rapid LFA-1 Surface Redistribution through a Protease- and PI(3)K-Dependent Signaling Pathway
Requirement for LFA-1 lateral mobility to chemokine-triggered lymphocyte adhesion inversely correlates with the site density of immobilized
ICAM-1. All lymphocytes were preincubated with buffer containing DMSO alone (no agonist and controls), or plus the inhibitors.
(A) Lymphocytes were stimulated at 378C for 2 min under stirring with buffer (a and b) or with 1 mM SLC (c and d) or for 10 min with 100 ng/
ml PMA (e and f). Shown are sequences of contiguous 0.6 mm thick slices, left, and 3D plots of fluorescence intensity and cell surface
distribution, right.
(B) Lymphocytes were pretreated with 100 mg/ml (280 mM) calpeptin and then stimulated at 378C for 2 min under stirring with 1 mM SLC (a),
or for 10 min with 100 ng/ml PMA (b). Controls are in (A), (c) and (d) and (e) and (f), respectively. Shown are sequences of contiguous 0.6 mm
thick slices.
(C) Eighteen-well glass slides were coated with ICAM-1 at the indicated number of sites/mm2. Lymphocytes were pretreated with the indicated
concentrations of calpeptin and then stimulated at 378C with buffer, no agonist, or for 2 min with 1 mM chemokine, or for 10 min with 100 ng/
ml PMA. Mean 6 SD counts of bound cells in three experiments.
(D). Lymphocytes were pretreated with 100 mg/ml calpeptin. Values are mean 6 SD percentage of total interacting cells during 30 s. Mean 6
SD values from three experiments.
(E) Lymphocytes were pretreated with 100 nM wortmannin (a) or with 20 mM LY294002 (b) and then stimulated at 378C for 2 min under stirring
with 1 mM SLC. Controls are in (A), (c) and (d). Shown are sequences of contiguous 0.6 mm thick slices.
LFA-1 redistribution was induced by SDF-1a and ELC Relevance of LFA-1 Lateral Mobility to Rapid
Chemokine-Triggered Lymphocyte Adhesion(data not shown). LFA-1 clustering was detectable even
after 10 s, the shortest assessable time point. In con- To evaluate whether LFA-1 lateral mobility was critical
to rapid lymphocyte adhesion by chemokines, we usedtrast, in lymphocytes treated with PMA for 10 min, LFA-1
showed a distribution to clusters without formation of calpeptin, a membrane permeable protease inhibitor
(Tsujinaka et al., 1988) recently shown to block LFA-1large polar patches. Cytofluorimetric analysis confirmed
that the overall levels of LFA-1 surface expression were clustering induced by agonists such as PMA, Ca21 mobi-
lizers, and (TcR)-CD3 (Stewart et al., 1998). As shownnot changed by chemokine stimulation (data not shown).
Furthermore, analysis of confocal images showed com- in Figure 3B and Table 1, calpeptin almost completely
prevented SLC-triggered rapid accumulation of LFA-1parable fluorescence intensity in nonstimulated, chemo-
kine, and PMA-triggered lymphocytes, whereas fluores- clusters and large polar patches. In control experiment,
calpeptin also inhibited PMA-triggered LFA-1 clustering.cence distribution was rearranged, clearly suggesting
molecular redistribution on the plasma membrane. In parallel experiments, calpeptin also inhibited chemo-
Chemokine-Triggered Integrin Affinity and Mobility
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Table 1. Protease and PI(3)K Inhibitors Block SLC-Triggered
Rapid LFA-1 Redistribution
Disperse Clusters Polar patches
No Agonist 82 6 5 15 6 7 3 6 0
SLC
Control 11 6 4 26 6 5 63 6 6
Calpeptin 80 6 3 17 6 8 3 6 0
Wortmannin 60 6 7 37 6 13 3 6 0
LY294002 52 6 14 44 6 4 4 6 2
PMA
Control 17 6 8 72 6 3 11 6 5
Calpeptin 70 6 9 26 6 10 4 6 0
Wortmannin 18 6 13 74 6 12 8 6 5
Lymphocytes were pretreated for 30 min at 378C with buffer con-
taining DMSO alone (no agonist and control) or plus 100 mg/ml
calpeptin, 100 nM wortmannin, or 20 mM LY294002 and then stimu-
lated for 2 min under stirring at 378C with buffer, no agonist, or with
1 mM SLC or for 10 min with 100 ng/ml PMA. At least 100 cells for
each data point were analyzed. Values are mean 6 SD percentage
of analyzed cells in three experiments.
kine-induced adhesion to ICAM-1 immobilized at 500
Figure 4. SLC-Triggered LFA-1 Lateral Mobility Is Critical to Lym-sites/mm2 (Figure 3C). Importantly, as for PI(3)K inhibi-
phocyte Arrest under Flow to Low-Density ICAM-1tors, calpeptin inhibited chemokine-triggered adhesion
SLC-triggered LFA-1 lateral mobility is critical to lymphocyte arrestonly to ICAM-1 immobilized at low but not at high densi-
under flow to low-density ICAM-1. Lymphocytes were preincubatedties. Furthermore, pretreatment with calpeptin did not
in buffer containing DMSO alone (control) or plus 100 nM wortman-block rapid arrest of circulating lymphocyte to HEV in
nin, 20 mM LY294002, or 100 mg/ml calpeptin and then passed
Peyer’s patches, as evaluated by intravital microscopy through capillaries cocoated with PNAd, the indicated density of
(Figure 3D). As for PI(3)K inhibitors, the lack of in vivo ICAM-1 and 2 mM SLC. Values are mean 6 SD percentage of total
interacting cells during 30 s (only rolling and rolling plus stickingeffect of calpeptin was not due to a wash-out effect, as
cells) from at least 10 separate 0.2 mm2 areas on the same capillarychemokine-triggered in vitro adhesion to low-density
tube. Values are from four experiments.ICAM-1 was still inhibited in pretreated cells maintained
in culture without inhibitor for 4 hr (data not shown). In
contrast, calpeptin inhibited PMA-triggered adhesion to Rapid Redistribution on the Plasma Membrane
ICAM-1 at both low and high site density (Figure 3C). of LFA-1 Is Critical to Chemokine-Triggered
Thus, calpeptin-sensitive protease-regulated LFA-1 lat- Lymphocyte Arrest on ICAM-1 under Flow Conditions
eral mobility is critical to chemokine-triggered rapid ad- Analysis by confocal microscopy showed LFA-1 redistri-
hesion in conditions of reduced presentation of integ- bution within 10 s. However, the possibility exists that
rin ligand to the lymphocyte. However, LFA-1 mobility actively induced LFA-1 lateral mobility is not rapid
on the plasma membrane is not required for lympho- enough to be relevant to lymphocyte rapid arrest under
cyte binding to high-density ICAM-1 or for in vivo arrest physiologic flow. Indeed, previous studies have shown
on HEV. that SDF-1a as well as ELC and SLC trigger rapid adhe-
sion to ICAM-1 of rolling lymphocyte in less than half a
second (Campbell et al., 1998).
Chemokine-Triggered LFA-1 Lateral Mobility To address this point, we evaluated the effect of PI(3)K
Is Regulated by Phosphatidylinositol 3-OH Kinase inhibitors and of calpeptin on chemokine-triggered lym-
To test whether PI(3)K was involved in chemokine-trig- phocytes adhesion to ICAM-1 under a physiologic shear
gered LFA-1 rapid lateral mobility, we evaluated LFA-1 of 2 dyne/cm2. Capillary tubes were cocoated with puri-
surface redistribution in lymphocytes pretreated with fied peripheral node addressin (PNAd), low or high num-
wortmannin and LY294002. As shown in Figure 3E and ber of sites/mm2 of ICAM-1, and chemokines. SLC data
Table 1, pretreatment with PI(3)K inhibitors prevented are presented as representative in Figure 4. Identical
SLC-triggered rapid accumulation of LFA-1 to clusters, results have been obtained with SDF-1a and ELC (data
with about 60% of the cells showing a disperse LFA-1 not shown). Nontreated cells rolled and adhered in an
distribution. Importantly, rapid LFA-1 localization to almost equivalent manner to areas coated either with
large polar patches was completely blocked. SDF-1a 500 or 6000 sites/mm2 of ICAM-1. When lymphocytes
and ELC-triggered LFA-1 redistribution was also pre- were pretreated with wortmannin, LY294002, or calpep-
vented by PI(3)K inhibition (data not shown). In contrast, tin, rolling on PNAd alone was unaffected (data not
PMA-induced slower formation of clusters was insensi- shown). Moreover, arrest and accumulation of cells in
tive to PI(3)K inhibition (data not shown). These data areas co-coated with PNAd, ICAM-1 6000 sites/mm2,
show that PI(3)K mediates chemokine-triggered rapid and SLC were also unaffected. In contrast, SLC-trig-
LFA-1 redistribution on lymphocyte plasma membrane gered lymphocyte adhesion to areas coated with 500
sites/mm2 of ICAM-1 was almost completely prevented,leading to clusters and large polar patches.
Immunity
764
with an average inhibition of 85%, 74%, and 91% for completely inhibited the increase of ICAM-1 binding trig-
gered by the three chemokines, thus confirming thatwortmannin, LY294002, and calpeptin, respectively.
This experiment indicates that under physiologic wall induction of LFA-1 high-affinity state was dependent on
heterotrimeric Gai-protein triggered inside-out signalingshear stress chemokine-triggered lymphocyte adhesion
to surfaces presenting low levels of integrin ligand re- events (Figure 5G).
quires active triggering of LFA-1 lateral mobility, whereas
chemokines can trigger arrest on high-density ICAM-1 Chemokine-Triggered LFA-1 High-Affinity State
independently of heterodimer lateral mobility-inducing Is Independent of Phosphatidylinositol 3-OH
signals. Kinase and Protease Activity
To support adhesion to high-density ICAM-1 or to Pey-
er’s patches HEV of lymphocyte pretreated with PI(3)KChemokines Trigger Rapid and Transient LFA-1
inhibitors or with calpeptin, affinity modulation must beHigh-Affinity State
independent of PI(3)K and calpeptin-sensitive proteaseWe hypothesized that LFA-1 affinity modulation might
activities. Indeed, as shown in Figure 5H, neither wort-be involved in rapid lymphocyte adhesion and that affin-
mannin, LY294002, or calpeptin affected the chemo-ity changes might be sufficient to mediate lymphocyte
kine-triggered increase of LFA-1 binding of solublearrest in settings of high ligand density. To test this
ICAM-1. Thus, proadhesive chemokines trigger in lym-hypothesis, we evaluated the capability of chemokines
phocytes very rapid and transient LFA-1 high-affinityto trigger binding of soluble mouse 125I-labeled ICAM-1,
state independently of PI(3)K-mediated signaling eventswhich allows the most direct and physiological evalua-
and of calpeptin-sensitive proteases.tion of LFA-1 high-affinity state.
Lymphocytes were presented simultaneously and
Discussionrapidly with chemokines and with soluble 125I-ICAM-1 by
adding the agonist and ICAM-1 to lymphocytes already
Our results reveal that (1) chemokines trigger LFA-1layered, in a small volume, on an oil cushion. This al-
high-affinity state within seconds; (2) induced affinitylowed rapid termination of the reaction by microcentrifu-
state is transient; (3) chemokines activate rapid lateralgation and analysis of very early time points. To evaluate
mobility of LFA-1 on the plasma membrane; (4) chemo-the ability of this assay to distinguish LFA-1 affinity state,
kine-triggered PI(3)K activity and protease activity controlwe took advantage of the observation that replacement
rapid LFA-1 lateral mobility but are not involved in LFA-1of Mg21 with Mn21 in the cell environment induces con-
affinity triggering; (5) LFA-1 lateral mobility is required forformational changes in integrins leading to a stable high-
chemokine-triggered rapid lymphocyte arrest to surfacesaffinity condition. Mn21-pretreated lymphocytes not only
presenting a low density of ICAM-1; (6) lymphocyte ar-displayed a sustained adhesion to ICAM-1-coated sur-
rest in HEV is independent of PI(3)K and thus does notfaces (Figure 5A) but also bound soluble ICAM-1 (Figure
require actively triggered LFA-1 lateral mobility.5B). Soluble ICAM-1 binding was not blocked by PTX
pretreatment but was prevented by anti-LFA-1 blocking
monoclonal antibody TIB213 (Figure 5B). Thus, our ex- Chemokine Triggering of LFA-1 High-Affinity State
Induction of conformational changes leading to en-perimental setting allowed detection of high-affinity
LFA-1. On the other hand, treatment of lymphocytes hanced integrin affinity has been widely recognized as
a central mechanism controlling integrin-mediated ad-with PMA, a stimulator of avidity but not affinity changes
(Stewart et al., 1998), induced efficient and long-lasting hesion (Bazzoni and Hemler, 1998). Enhanced affinity
allows integrins to bind ligands in solution (Bazzoni andLFA-1-dependent adhesion to immobilized ICAM-1 (Figure
5C) but failed to allow LFA-1 binding of the soluble ligand Hemler, 1998). Integrin affinity regulation evidenced by
soluble ligand binding induced by physiological stimuli(Figure 5D). Thus, our assay system allows effective dis-
crimination between two activated, proadhesive states has been previously shown for the platelet fibrinogen
receptor (aIIbb3) (Shattil et al., 1985). In contrast, bindingof LFA-1, a conformationally altered high-affinity state
capable of binding soluble ICAM-1 and a low-affinity of soluble ICAM-1 to LFA-1 has only been shown in the
context of artificial integrin activation through alteredbut high-avidity state exemplified by the PMA activation.
We next examined the ability of chemokines to trigger cation treatment of lymphocytes in vitro. Indeed, the
relevance of LFA-1 affinity modulation to the regulationhigh-affinity state on LFA-1. As shown in Figure 5E, SDF-
1a, ELC, and SLC triggered extremely rapid lymphocyte of lymphocyte adhesion under physiological conditions
has remained controversial.binding to soluble ICAM-1. Binding was already detect-
able after 15 s, the earliest time-point measurable, and Here, we show that SLC, ELC, and SDF-1a promote
binding of soluble native ICAM-1 to lymphocytes, dem-was maximal after 2 min in the case of SDF-1a and ELC.
Interestingly, the response to SLC showed an acceler- onstrating that a LFA-1 high-affinity state can be trig-
gered by physiologically relevant stimuli in lymphocytes.ated kinetics, with maximal binding after 1 min. Notably,
prolonged stimulation resulted in binding downmodula- This chemokine-induced affinity triggering is rapid (oc-
curring within seconds) and transient (reverting to lowtion, with about 50% reduction within 4 min in case of
SDF-1a and ELC and within 3 min for SLC. By 6 min, affinity within minutes), corresponding to the kinetics of
induced lymphocyte adhesion in in vitro flow assayschemokine-induced binding of soluble ICAM-1 was
completely downregulated. ICAM-1 binding was abro- and to the rapid but reversible arrest of lymphocytes
interacting with HEV in lymphoid organs. In fact, onegated by anti-LFA-1 antibody, showing that ICAM-1
binding was specifically dependent on LFA-1 (Figure of the pro-adhesive chemokines studied here, SLC, is
presented by lymphoid organ’s high endothelial venules5F). Furthermore, pretreatment of lymphocytes with PTX
Chemokine-Triggered Integrin Affinity and Mobility
765
Figure 5. Chemokines Trigger a Rapid and Transient High-Affinity State on LFA-1 Independently of Protease and PI(3)K
(A) Eighteen-well glass slides were coated with ICAM-1 at 3000 sites/mm2. Lymphocytes were Mn21-activated and allowed to adhere to
immobilized ICAM-1 for 3 min.
(B) Lymphocytes were Mn21-activated and then pretreated with buffer (control) or with the anti-LFA-1 blocking antibody TIB213; PTX pretreat-
ment was done before Mn21 activation. Lymphocytes were then exposed to soluble 125I-ICAM-1 for 3 min.
(C) Eighteen-well glass slides were coated with ICAM-1 at 500 sites/mm2 . Lymphocytes were stimulated with buffer (no agonist) or with 100
ng/ml PMA for the indicated times.
(D) Lymphocytes were exposed at the same time to 125I-ICAM-1 and buffer (no agonist) or 100 ng/ml PMA for the indicated times.
(E) Lymphocytes were exposed at the same time to 125I-ICAM-1 and buffer (no agonist) or 1 mM chemokine for the indicated times.
(F–G) Lymphocytes were pretreated with buffer (control) or with the anti-LFA-1 blocking antibody TIB 213 or with PTX and then exposed at
the same time to 125I-ICAM-1 and buffer (no agonist) or 1 mM chemokine for 2 min.
(H) Lymphocytes were preincubated in buffer containing DMSO alone (control) or plus 100 nM wortmannin, 20 mM LY294002, or 100 mg/ml
calpeptin, and then exposed at the same time to 125I-ICAM-1 and buffer (no agonist) or 1 mM chemokine for 2 min.
Values are mean counts of bound cells presented with standard deviation from four experiments (A-C) or CPM from a representative experiment
(B-D-E-F-G-H).
and plays a critical role in triggering the arrest of recircu- ing. For instance, cation-ligand-influenced binding-site
(CLIBS) epitopes appear as a consequence of ligandlating T cells on these specialized vessels during lym-
phocyte homing to LN in vivo (Gunn et al., 1999; Warnock binding, and Bazzoni and Hemler (1998) have empha-
sized that CLIBS epitopes should not be regarded aset al., 2000).
Although binding of soluble ligand is the most direct activation epitopes. Indeed, anti-LFA-1 mAb 24 recog-
nizes such a CLIBS epitope and it does not appear tomeasure of integrin affinity, antibodies to conformation-
ally sensitive integrin epitopes have also been used to detect the chemokine-triggered but ligand-independent
high-affinity state revealed in our studies (Tangemannmonitor integrin conformational alterations. “Ligand-
mimetic” antibodies recognize activation epitopes whose et al., 1998).
Ganpule et al. (1997) have proposed a model of ligand-appearance corresponds closely to the high-affinity
state (Bazzoni and Hemler, 1998). Notably, RANTES, induced LFA-1 affinity activation as a consequence of
previous low-affinity interactions of clustered LFA-1 withMCP-3, and the anaphylatoxin C5a have been shown
to trigger in eosinophils a prolonged expression of an ICAM-1 (Ganpule et al., 1997). Our results, in contrast,
support a role for ligand-independent mechanisms ofactivation epitope on the b2-integrin CR3 (Weber et al.,
1996). On the other hand, not all integrin neoepitopes affinity modulation through inside-out signaling. Of
course, an initial LFA-1 high-affinity state triggered bycorrelate with an increased potential for ligand bind-
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Figure 6. Model of Chemokine-Triggered
LFA-1-Dependent Rapid Lymphocyte Ad-
hesion
Chemokine-triggered signaling induces in-
tegrin high-affinity state and, through the co-
ordinated action of cytosolic proteases and
PI(3)K, rapid heterodimer lateral mobility
(top). When lymphocytes interact with a sur-
face presenting low density of ligand, accel-
erated lateral mobility facilitates ligand en-
gagement of integrins in high-affinity state
(middle). For example, the integrin in position
A, which is close to the ligand, can promptly
be engaged; in contrast the integrins in posi-
tion B-C and D must move to B9-C9 and D9
positions to encounter the ligand. This proc-
ess is not required when lymphocytes are
presented with a high density of ligand. In this
last case, rapid arrest is mediated by affinity
alone (bottom).
chemokines may be followed, under physiological con- creased affinity but also by receptor lateral mobility on
the plasma membrane, which allows clustering and in-ditions, by longer lasting ligand-induced affinity changes
that could prolong the stable interaction of lymphocytes creased avidity. Increased LFA-1 clustering leading to
enhanced avidity is in fact the dominant mechanismwith HEV. However, in our model chemokine-triggered
LFA-1 clustering was a rather long-lasting phenomenon controlling lymphocyte adhesion induced by PMA, Ca21
mobilizers, and (TcR)-CD3 (Stewart et al., 1998). Notably,when compared to transient affinity triggering, and even
in presence of clustered integrins, affinity downmodula- these agonists do not actively trigger LFA-1 to a high-
affinity state (Stewart et al., 1996), and in each of thesetion led to cell deadhesion. This suggests that integrin
redistribution is not sufficient to stabilize rapid lympho- models, stimulated LFA-1 mobility and avidity changes
are induced relatively slowly, over minutes.cyte arrest under physiologic shear forces and highlights
the prominent role of chemokine-induced active affinity In contrast, we show that chemokines stimulate an
extremely rapid LFA-1 redistribution, occurring withintriggering in rapid lymphocyte adhesion. However, until
we identify a specific and selective inhibitor of affinity seconds. This lateral mobility appears to be actively
driven by intracellular forces generated by chemokine-changes, we will not be able to formally exclude that
lymphocyte arrest can be mediated, in some instances, triggered inside-out signaling events and independent
of ligand engagement, as formation of clusters occurs inby mobilization and avidity changes alone.
nonadherent cells. Moreover, our studies demonstrating
that PI(3)K and protease inhibitors prevent chemokine-Chemokine Triggering of LFA-1 Lateral Mobility
in Rapid Adhesion triggered lymphocyte arrest on low-density ICAM-1
even under flow (see below) suggest that LFA-1 lateralIntegrin function can be modulated not only by confor-
mational changes of the heterodimer leading to in- mobility can be triggered on a subsecond time frame.
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PI(3)K may play an essential role in this chemokine- lateral movement on the plasma membrane, thus accel-
erating cluster and polar patch formation.accelerated mobilization of LFA-1. PI(3)K is activated by
chemokines within seconds, as shown here for signaling
through CCR7 (and previously for CXCR4 [Ganju et al., A Model of Chemokine-Triggered Integrin Activation
1998]). Moreover, inhibition of PI(3)K blocks chemokine- In conclusion, our data suggest a model in which chemo-
triggered LFA-1 redistribution. Importantly, this require- kines activate rapid lymphocyte arrest under physiologi-
ment for PI(3)K distinguishes chemokine-triggered rapid cal conditions by triggering LFA-1 high-affinity state and
redistribution from the delayed LFA-1 redistribution as- rapid lateral mobility (Figure 6). The coordinated action
sociated with PMA stimulation. PI(3)K may also mediate of proteases and PI(3)K removes initial cytoskeletal re-
the unique polar distribution of LFA-1 induced by che- straints and triggers extremely rapid redistribution of
mokines, as this asymmetric pattern is not observed LFA-1 on the plasma membrane, thus enhancing the
after PMA stimulation and is also inhibited by PI(3)K probability of encounters between the affinity-activated
inhibitors. A calpeptin-sensitive protease activity is also integrins and their immobilized ligands. Due to the ap-
essential for LFA-1 mobility but, in contrast to the selec- parent prominent role of affinity triggering, we predict
tive involvement of PI(3)K, calpeptin prevents both PMA that chemokines unable to trigger LFA-1 to a high-affin-
and chemokine-triggered LFA-1 redistribution. ity state should be also unable to induce rapid adhesion
Importantly, both PI(3)K and calpeptin-sensitive pro- to ICAM-1. On the other hand, triggering of LFA-1 lateral
tease activities are critical for chemokine-triggered lym- mobility is critical for integrin-ligand engagement only
phocyte arrest under conditions of limiting ICAM-1 den- during adhesion to surfaces expressing low levels of
sity. We propose that this reflects a requirement for ICAM-1. Notably, ICAM-1 expression on endothelial
rapid LFA-1 mobility in order to enhance the frequency cells can be modulated, with variable and transient ki-
of encounters between high-affinity LFA-1 and disperse netics, by different proinflammatory agonists, such as
immobilized ligand. Consistent with this interpretation, IL-1, TNFa, and gIFN (Pober et al., 1986). Thus, de-
neither PI(3)K nor protease activities are required for pending on the stage and kind of the immune reaction,
efficient chemokine-triggered lymphocyte arrest when PI(3)K-dependent rapid LFA-1 lateral mobility may be
ligand is not limiting; in this setting, enhanced affinity particularly relevant for lymphocyte arrest in inflamed
appears sufficient to mediate adhesion. Importantly, af- vessels still not presenting optimal levels of endothelial
finity triggering is likely to be sufficient for lymphocyte integrin ligands.
arrest in vivo as well. Indeed, PI(3)K inhibitors and cal-
Experimental Procedurespeptin do not prevent lymphocyte arrest and homing
via HEV, where ICAM-1 site density is very high. More-
Materials
over, in addition to ICAM-1, HEV express ICAM-2, so PMA, ketamine, and xylosine were from Sigma; RPMI 1640 was
that the total density of LFA-1 ligands may be even from Bio Whitaker; FCS was from Irvine; murine SLC, human SDF-
higher. These characteristics of chemokine-triggered 1a, and ELC were from Peprotech (London, England); Wortmannin,
LY294002, calpeptin, and Pertussis toxin were from Alexis; ML7adhesion, again, stand in contrast to adhesion induced
and KT5926 were from Calbiochem; rabbit polyclonal antibody anti-by PMA, which is inhibited by calpeptin regardless of
PI(3)kinase p85 conjugated to agarose-protein A was from UBI;the density of ICAM-1 available. Together, these data
125NaI, [32P]-g-ATP, and [32P]orthophosphate were from Amersham;
suggest that integrin mobility may have different roles CMFDA, CMTMR, and Alexa 488 labeling kit were from Molecular
in slow, PMA-stimulated adhesion versus rapid chemo- Probes; glass capillary tubes were from Drummond, PA; Texas Red-
kine-triggered arrest. In the case of PMA stimulation, conjugated goat anti-rat secondary antibody was from Jackson Im-
munoResearch; murine ICAM-1 and human PNAd were purified fromwhich is not associated with integrin affinity changes,
spleens and tonsils, respectively (Campbell et al., 1998). To studyintegrin lateral mobility may be essential for induction
the effect of the inhibitors, the cells were preincubated for 30 minof clustering and enhanced avidity. In the context of
at 378C in buffer containing DMSO alone (no more than 0.2%) or
chemokine-induced adhesion, lateral mobility may en- plus the inhibitor (DMSO did not interfere with any of the studied
hance the probability of (high-affinity) integrin-ligand en- phenomena up to 2%)
counters.
In Vitro Static Adhesion Assay to Mouse ICAM-1How do proteases and PI(3)K regulate rapid LFA-1
Peripheral and mesenteric lymph nodes and Peyer’s patches werelateral mobility induced by chemokines? Calpeptin has
isolated from young BALB/c mice (Harlan, Italy). Adhesion assaysbeen shown to inhibit the activity of the neutral protease
were done on eighteen-well glass slides coated overnight at 48C
Calpain (Tsujinaka et al., 1988). Indeed, a Calpain-depen- with purified mouse ICAM-1 (Laudanna et al., 1996); site density per
dent cleavage of cytoskeletal restraints leading to integ- square micrometer of immobilized ICAM-1 was calculated (Law-
rin lateral movement has been proposed as general rence and Springer, 1991). Lymphocytes were activated with Mn21
as described (Berlin et al., 1993).mechanism of LFA-1 activation by agonists able to trig-
ger intracellular Ca21 flux (Stewart et al., 1998). Thus,
Analysis of PI(3)K Kinase Activityan intracellular Ca21 flux induced by chemokines could
Lymphocytes were resuspended in PBS, CaCl2 1 mM, MgCl2 1 mM,activate Calpain-dependent signaling events that allow and 10% FCS (pH 7.2), stimulated with agonists under stirring, and
free lateral movement of LFA-1 on the plasma mem- then lysed in ice-cold lysis buffer containing Tris-HCl 50 mM (pH
brane. Notably, calpeptin is not an entirely specific Cal- 8.0), NP-40 1%, NaCl 150 mM, and protease inhibitors. Lysates were
then centrifuged at 13.0003g and immune precipitated for 2 hr at 48Cpain inhibitor, suggesting that other proteases might be
with a rabbit polyclonal antibody anti-PI(3)kinase p85 conjugated toinvolved in LFA-1 lateral mobility regulation. Alterna-
agarose-protein A. Immunoprecipitates were then washed twicetively (or in addition), as PI(3)K is implicated in cytoskele-
with lysis buffer, once with LiCl 0.5 mM, and once with HEPES 30
tal remodeling, activation of PI(3)K could direct fast mM, EGTA 1 mM (pH 7.4). In vitro kinase assay was carried out
cytoskeletal reorganization leading, upon cytoskeletal directly on the beads (Vlahos et al., 1994). Radioactivity incorporated
into phosphatidylinositol was measured by electronic autoradiogra-interaction with the released heterodimer, to rapid LFA-1
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phy of chromatograms using an Instant Imager (Packard). Alterna- cence (as total gray level value), and the defined ICAM-1 site density.
The standard curve (500–1000–2000–3000–6000 sites/mm2) was cal-tively, to evaluate the efficacy of wortmannin and LY294002 to pre-
vent PI(3)K activity, the accumulation of PIP3 was measured in culated by averaging values from ten different fields for each site/
density (with a standard deviation between fields no greater than[32P]orthophosphate-labeled lymphocytes upon chemokine trig-
gering (Vlahos et al., 1994). 2%) and was perfectly linear. The coated slides gave the same
results whether examined en face or on edge, by optical sectioning.
Intravital Video Microscopy Analysis of Lymphocyte-High
In Vitro under Flow Adhesion AssayEndothelial Venule Interaction in Peyer’s Patches
100 ml microcap glass capillary tubes were first coated for 10 hr atLymphocytes (5 3 106/ml in DMEM without sodium bicarbonate
48C with 20 ml of human PNAd; tubes were then coated overnightsupplemented with 20 mM Hepes and 5% FCS [pH 7.1]) were labeled
at 48C with 10 ml of ICAM-1 at the dilutions used to immobilize eitherwith either CMFDA or CMTMR for 45 min at 378C. Labeled cells
500 or 6000 sites/mm2 on slides. Before use, tubes were treated(30 3 106) were injected i.v. In situ videomicroscopic analyses were
with FCS for 5 min and then coated with 20 ml of 2 mM chemokinescarried out as described (Bargatze and Butcher, 1993). Cell behav-
for 20 min. After washing with PBS, the behavior of interactingiors were analyzed over a period of 20 min from 2 min after i.v.
lymphocytes was recorded on S-VHS videotape and analyzed frameinjection. Interactions of $1 s were considered significant and were
by frame (Campbell et al., 1998). Single areas of 0.2 mm2 werescored. Cells were considered to be interacting whether they rolled,
recorded for at least 30 s. Interactions (rolling, arrest, or both) ofarrested, or both. Lymphocytes that remained firmly adherent on
$1 s were considered significant and were scored. Lymphocytesvenular wall for $10 s were considered firmly adherent. “Stop-and-
that remained firmly adherent for $10 s were considered fully ad-go” interactions of ,1 s were not scored for data analysis.
herent.Immunofluorescence Staining and Confocal Imaging Analysis
To study the surface distribution of LFA-1, a confocal imaging sys-
tem was used. Lymphocytes were stimulated in suspension under Measurement of LFA-1 High-Affinity State
stirring and then immediately fixed in 1% ice-cold paraformaldehyde b-octyl glucoside was removed from the preparation of mouse
in PBS (pH 7.4) for 10 min. Cells were washed and incubated with ICAM-1 by using the Extracti-Gel D Detergent Removing kit (Pierce).
10 mg/ml of TIB213 rat anti-mouse LFA-1 (ATCC) for 30 min on The Extracti-Gel column was equilibrated with 50 mM Tris (pH 9.0).
ice, washed 33, and then incubated for 30 min with Texas Red- Eluted ICAM-1 was then dialyzed against 25 mM Tris-HCl (pH 7.5)
conjugated goat anti-rat secondary antibody. The washed cells ad- and 0.4 M NaCl. 50 mg of soluble ICAM-1 was iodinated with 1 mCi
hered for 30 min at 48C on 0.1% poly-L-lysine coated round 13 mm 125NaI by the Chizzonite method using IODO-GEN precoated tubes
glass coverslips. The cells were washed, rinsed in absolute ethanol (Pierce). Iodide was preactivated at room temperature for 8 min and
and once in PBS, and then mounted in 30% glycerol. Fluorescent immediately added to the protein solution. Iodination was carried
specimens were analyzed with a Carl Zeiss LSM 510 confocal im- out at room temperature for 9 min and stopped by adding 50 ml of
aging system, with a 633 C-Apochromat objective (NA 1.2). The 25 mM Tris-HCl (pH 7.5), 0.4 M NaCl, containing 10 mg/ml tyrosine.
cells were serially scanned in horizontal sections 0.6 mm apart. 125I-ICAM-1 was run over a PD10 desalting column and eluted with
LFA-1 distribution was quantified by using the LSM 510 image analy- 300 ml of PBS containing 1 mg/ml BSA and then kept at 48C. The
sis software. Comparison between nonstimulated versus stimulated binding assay was done at 378C in a 500 ml Eppendorf tube in a
lymphocytes allowed identification of three different morphologies final volume of 50 ml. 40 ml of lymphocyte suspension (5 3 107/ml
of LFA-1 distribution. Analysis of nonstimulated cells showed LFA-1 in PBS containing 1 mg/ml BSA, 2 mM MgCl2, 1 mM CaCl2, and 1
localization to small dots with a mean area 6 SD of 0.1 6 0.08 mm2. mM D-glucose [pH 7.2]) was directly layered on 100 ml oil cushion
In this case, LFA-1 was considered “disperse.” LFA-1 localized to of 2/1 dibutyl/dioctyl phthalates. The high surface tension of the
bigger dots was considered “clustered.” In PMA-treated cells, LFA-1 dibutyl/dioctyl phthalates mixture allowed the formation of a spheri-
was localized to dots with a mean area of 0.8 6 0.4 mm2, and thus cal drop (binding chamber) of cell suspension immediately under
was considered clustered. In case of chemokine-stimulated cells, the surface of the oil cushion. Lymphocytes were stimulated by
LFA-1 also showed an asymmetric localization to polar regions with directly injecting into the binding chamber 10 ml of PBS containing
a mean area of 2.4 6 1.1 mm2, and thus was considered localized chemokines (5 mM) or PMA (500 ng/ml) and 125I-ICAM-1 (5 3 105 CPM
to “polar patches.” Notably, the average percentage distribution of corresponding approximately to 1 mg of 125I-ICAM-1). The binding
total fluorescence to dots or to polar patches was 30 6 14% in reaction was stopped by centrifugation in microfuge (about 6 s to
nonstimulated cells, 65 6 10% in PMA-treated cells, and 71 6 19% stop the reaction). The aqueous and oil phases were then removed
in chemokine-stimulated cells, with residual fluorescence appearing and the pellet of lymphocytes counted with a gamma counter. In
diffuse. In the inhibition experiments, the percentage of lymphocytes case of Mn21 activation, binding to soluble 125I-ICAM-1 was done
showing each one of these morphologies was calculated. in presence of Mn21 instead of Mg21. For the inhibition studies,
lymphocytes were pretreated with TIB 213 antibody (30 mg/ml/30
min) or with Pertussis toxin (150 ng/ml/2 hr). In the case of Mn21Measurement of ICAM-1 Site Density on HEVs
activation, lymphocytes were pretreated with PTX before Mn21The rat anti-mouse ICAM-1 antibody YN 1.1.7.4 (ATCC) was labeled
treatment.with Alexa 488. 50 mg of antibody were injected i.v.; after 15 min,
the mouse was sacrificed and perfused with 20 ml of PBS followed
by 10 ml of PBS-1.5% paraformaldehyde. 10 mm cryostatic sections Acknowledgments
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